eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 26/03/2012
PIL Isentress 400 mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/03/2012 and displayed until 26/03/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 02/12/2011 and displayed until 01/03/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 24/09/2010 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/04/2010 and displayed until 24/09/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 18/09/2009 and displayed until 15/04/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 28/07/2009 and displayed until 18/09/2009
Reasons for adding or updating:
  • Change to Further Information section
Updated on 12/05/2009 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 20/01/2009 and displayed until 12/05/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 17/09/2008 and displayed until 20/01/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/05/2008 and displayed until 17/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 04/01/2008 and displayed until 27/05/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   raltegravir potassium